FDA Approves Pembrolizumab Plus Pemetrexed and Platinum Chemotherapy for Malignant Pleural Mesothelioma
Pembrolizumab (Keytruda; Merck) plus pemetrexed (Alimta; LillyMedical) and platinum chemotherapy in the first line received FDA approval for the treatment of adult patients with unresectable advanced or metastatic malignant pleural mesothelioma (MPM). …